glp 1 oral novo nordisk launched an version of its GLP-1 injectable to US markets on Jan 5. Link in comments Novo Nordisk Finds Medicare Patients

Dual-epitope BsADC targeting HER2 ZW49: ZW49 is generated from the conjugation of a novel N-acyl sulfonamide auristatin payload to the inter-chain disulfide bond cysteines of the Bispecific anti-HER2 IgG1 antibody ZW25 (now known by its generic name, zanidatamab), via a protease cleavable linker

Strbe et al., 2021), in rats with severely increased intra-abdominal pressure, i.e., primary abdominal compartment syndrome, we attempted to introduce a therapy for compressed essential vessel tributaries, both arterial and venous (peripherally and centrally), due to occluded major veins and arteries, in order to prevent the consequent noxious syndrome, both peripherally and centrally

Prominent players in the GLP-1 market include Novo Nordisk, Eli Lilly and Company, Pfizer Inc., AstraZeneca Plc, and others

H., Yen, M

The number of bacteria was counted using the dilution-plate counting method